LGMK: LogicMark, Inc. Stock

by  •  • Comments Off on LGMK: LogicMark, Inc. Stock

SIC 3842 – Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Valuation
Market Cap ($M) 0.78
Enterprise Value ($M) -0.43
Book Value ($M) 12.19
Book Value / Share 0.20
Price / Book 0.06
NCAV ($M) 3.31
NCAV / Share 0.05
Price / NCAV 0.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 2.01
Current Ratio 2.63

Balance Sheet (mrq) ($M)
Current Assets 5.34
Assets 14.22
Liabilities 2.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.90
Operating Income -7.67
Net Income -9.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.25
Cash from Investing -1.46
Cash from Financing 3.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-27 13G Bigger Capital Fund L P 9.78
02-21 13G L1 Capital Global Opportunities Master Fund, Ltd. 9.99
12-03 13D/A Winvest Investment Fund Management Corp. 0.00
11-14 13G Anson Funds Management LP 9.90
08-09 13G Altium Capital Management LP 9.99
08-07 13D/A Simmons Chia-Lin 3.50 16.31

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 518,329,845 1,644,259,356 31.52
2025-04-28 310,984,352 1,077,749,233 28.85
2025-04-25 11,604,050 39,994,091 29.01
2025-04-24 7,840,895 36,947,171 21.22

(click for more detail)

Similar Companies
IRIX – IRIDEX Corporation KRMD – KORU Medical Systems, Inc.
LFWD – Lifeward Ltd. LNSR – LENSAR, Inc.
LUCD – Lucid Diagnostics Inc.


Financial data and stock pages provided by
Fintel.io